EverspanTruAge Epigenetic Clock Testing
Research-based epigenetic age testing that measures DNA methylation patterns to estimate biological aging relative to chronological age.
Human Trials
15
8,500 participants
Risk Level
Monthly Cost
One-time test cost, typically repeated annually or semi-annually
Quick Facts
- Category
- Other
- Research Field
- Epigenetics
- Evidence Grade
- B – Moderate
- Risk Level
- Low
- Monthly Cost
- $300 – $500
- Human Trials
- 15
Research Velocity
Mechanism of Action
TruAge testing analyzes DNA methylation patterns at specific CpG sites associated with aging to calculate biological age. The test uses saliva or blood samples to measure epigenetic markers that change predictably with age, providing an estimate of how fast an individual is aging at the cellular level compared to their chronological age.
Overview
TruAge epigenetic clock testing represents a commercial application of breakthrough research in aging biomarkers, using DNA methylation patterns to estimate biological age. Studies indicate that these tests analyze specific cytosine-guanine dinucleotide (CpG) sites where methylation changes predictably with age, providing insights into cellular aging processes that may differ from chronological age.
Research suggests that epigenetic clocks like those used by TruAge can be responsive to lifestyle interventions, with studies showing changes in biological age estimates following diet, exercise, and other longevity-focused interventions. The testing typically requires a simple saliva sample and provides reports on biological age relative to chronological age, along with recommendations for potentially slowing aging processes.
While the underlying science of DNA methylation and aging is well-established, the clinical utility and accuracy of commercial epigenetic age testing continues to be evaluated. Studies indicate reasonable correlation between epigenetic age estimates and health outcomes, though researchers note that interpretation should consider individual variation and the evolving nature of aging biomarkers research.
Known Interactions
- No direct interactions with medications or supplements
- Test results may be influenced by acute illness, stress, or recent lifestyle changes
- Smoking, alcohol consumption, and diet can affect DNA methylation patterns measured
Legal Status by Country
Your country (United States)
Available without prescription in:
Australia, Canada, Germany, Israel, Mexico, Netherlands, Switzerland, United Kingdom, United States, Colombia, India, Panama, Russia, Thailand, Turkey, UAE
📍 = your selected country · ✈️ = medical tourism destination · Always verify current local regulations before travel.
Key Research
- 2020
Validates accuracy of DNA methylation-based aging clocks
- 2021
Reviews commercial epigenetic testing including TruAge platform
- 2020
Demonstrates responsiveness of epigenetic age to lifestyle interventions
- 2022Validation of saliva-based epigenetic age estimation in a longitudinal cohort
Validates saliva sampling method used by TruAge testing
Related Interventions
Biological Age Testing (Epigenetic Clocks)
DNA methylation analysis to estimate biological aging rate and age-related disease risk through epigenetic clock algorithms.
Advanced Lipid Panel (NMR/Ion Mobility)
Research indicates advanced lipid testing methods like NMR and ion mobility provide more detailed cardiovascular risk assessment than standard lipid panels.
AI-Personalized Nutrition
Machine learning algorithms analyze individual biomarkers and genetics to create personalized dietary recommendations for optimal health outcomes.
Comprehensive Blood Panel Monitoring
Regular comprehensive blood testing for early detection of health issues and optimization of biomarkers linked to longevity.
Last verified: 2026-03-19